Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
15373901000001115 | Ferrous sulphate 4mg / Silica 1.6mg tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
75154001000001116 | Ferrous sulfate 4mg / Silica 1.6mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bidor 5% tablets (Weleda (UK) Ltd) | Is a | True | Ferrous sulphate 4mg / Silica 1.6mg tablets | Inferred relationship | Existential restriction modifier | |
Ferrous sulphate 4mg / Silica 1.6mg tablets 100 tablet | Is pack of | False | Ferrous sulphate 4mg / Silica 1.6mg tablets | Inferred relationship | Existential restriction modifier | |
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet | Is pack of | False | Ferrous sulphate 4mg / Silica 1.6mg tablets | Inferred relationship | Existential restriction modifier | |
Ferrous sulphate 4mg / Silica 1.6mg tablets 100 tablet | Has VMP | True | Ferrous sulphate 4mg / Silica 1.6mg tablets | Inferred relationship | Existential restriction modifier | |
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet | Has VMP | True | Ferrous sulphate 4mg / Silica 1.6mg tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets